Please login to the form below

Not currently logged in
Email:
Password:

bioelectronics

This page shows the latest bioelectronics news and features for those working in and with pharma, biotech and healthcare.

Gilead and Verily team up to map inflammatory diseases

Gilead and Verily team up to map inflammatory diseases

The alliance with Gilead adds to Verily’s joint ventures with GSK, Galvani Bioelectronics and with Sanofi ’s diabetes management platform Onduo.

Latest news

  • GSK and Google launch bioelectronics venture GSK and Google launch bioelectronics venture

    GSK and Google launch bioelectronics venture. Will develop electronic implants to treat chronic diseases, including diabetes. ... GlaxoSmithKline has joined forces with Google's Verily Life Sciences to establish a new company dedicated to the development

  • Things can only get better Things can only get better

    For instance, bioelectronic medicine - an emerging technology - raises the prospect of implants being used to treat chronic conditions without the need for pills or injections.

  • Coming together Coming together

    Add to this areas like bioelectronics, which GSK is dabbling in, and we see the line between pharma and medtech becoming less clear than ever.

  • GSK expands bioelectronics efforts with $5m challenge fund GSK expands bioelectronics efforts with $5m challenge fund

    GSK expands bioelectronics efforts with $5m challenge fund. Will support academics and small companies working to stimulate and block neural signals in organs. ... GlaxoSmithKline (GSK) is setting up a $5m fund for external researchers working in the

  • Pharma’s four options for innovation Pharma’s four options for innovation

    With bioelectronics GSK has placed a true bet on the future with little predictability of outcome. ... For instance GSK is investing in bioelectronics.

More from news
Approximately 5 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    There was the August announcement that Google's Verily company was investing in the development of bioelectronic medicines with GSK via the newly formed Galvani Bioelectronics.

  • Deal Watch August 2016 Deal Watch August 2016

    GSK had got the message back in 2012 when it set up a bioelectronics medicines group. ... GSK will hold 55% of the shares in Galvani Bioelectronics, which will seek to develop miniaturised devices, attached to individual nerves to correct irregular

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Medicxi appoints former GSK chair Moncef Slaoui Medicxi appoints former GSK chair Moncef Slaoui

    Dr Slaoui takes on the role alongside his other board positions, which include chairman of the board at Galvani Bioelectronics, and on the boards of Artisan Biosciences, Moderna Therapeutics and Sutovax.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics